Publications

5674 Results

Intergroup 0144 - phase III trial of 5-FU based chemotherapy regimens plus radiotherapy (XRT) in postoperative adjuvant rectal cancer. Bolus 5-FU vs prolonged venous infusion (PVI) before and after XRT + PVI vs bolus 5-FU + leucovorin (LV) + levamisole (LEV) before and after XRT + bolus 5-FU + LV.

Authors
SR Smalley;J Benedetti;S Williamson;J Robertson;B Fisher;J Martenson;AB Benson;M Robert;C Cripps;J Macdonald
Journal / Conference
Proc of the American Society of Clinical Oncology 22:251(#1006)
Year
2003
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9304 (INT-0144)

Phase III dose-randomized study of imatinib mesylate (STI571) for GIST: Intergroup S0033 early results.

Authors
RS Benjamin;C Rankin;C Fletcher;C Blanke;M Von Mehren;R Maki;V Bramwell;L Baker;E Borden;GD Demetri
Journal / Conference
Proc of the American Society of Clinical Oncology 22:814(#3271)
Year
2003
Research Committee(s)
Sarcoma
Study Number(s)
S0033

Surgical variables impact bladder cancer outcomes: a cooperative group report.

Authors
HW Herr;J Faulkner;HB Grossman;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 22:383(#1540)
Year
2003
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)

Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIa non-small cell lung cancer (NSCLC) leads to higher than expected risk of death from intercurrent disease (DID).

Authors
HA Wakelee;P Stephenson;SM Keller;H Wagner;A Herskovic;R Komaki;RS Marks;MC Perry;RB Livingston;DH Johnson
Journal / Conference
Proc of the American Society of Clinical Oncology 22:633(#2545)
Year
2003
Research Committee(s)
Lung
Study Number(s)
SWOG-9252 (INT-0115) (EST-3590) (RTOG 91-05) (NCCTG-91-24-51) (CALGB-9393)

Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group study.

Authors
RP Whitehead;S McCoy;J Macdonald;SE Rivkin;M Neubauer;S Dakhil;H-J Lenz;M Tanaka;JL Abbruzzese
Journal / Conference
Proc of the American Society of Clinical Oncology 22:272(#1092)
Year
2003
Research Committee(s)
Gastrointestinal
Study Number(s)
S9923

Time from treatment to subsequent diagnosis of brain metastases in Stage III non-small cell lung cancer (NSCLC): a retrospective review by the Southwest Oncology Group (SWOG)

Authors
LE Gaspar;K Chansky;KS Albain;E Vallieres;V Rusch;J Crowley;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 22:636(#2558)
Year
2003
Research Committee(s)
Lung
Study Number(s)
SWOG-8805, SWOG-9019, SWOG-9416, SWOG-9509

Evaluation of ZD1839 for advanced transitional cell carcinoma (TCC) of the urothelium: a Southwest Oncology Group trial

Authors
D Petrylak;JR Faulkner;PJ Van Veldhuizen;M Mansukhani;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 22:403(#1619)
Year
2003
Research Committee(s)
Genitourinary
Study Number(s)
S0031

Phase III comparison of tamoxifen versus tamoxifen with ovarian ablation in premenopausal women with axillary node-negative receptor-positive breast cancer < 3 cm

Authors
NJ Robert;M Wang;D Cella;S Martino;D Tripathy;J Ingle;LJ Solin;WC Wood
Journal / Conference
Proc of the American Society of Clinical Oncology 22:5(#16)
Year
2003
Research Committee(s)
Breast
Study Number(s)
SWOG-9347 (INT-0142) (E3193)

Phase III study of conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem cell transplantation in patients with stage II and III breast cancer at high risk of recurrence (INT 0121)

Authors
M Tallman;R Gray;N Robert;C Osborne;W Vaughan;W Gradishar;T Pisansky;J Fetting;E Paietta;H Lazarus
Journal / Conference
Proc of the American Society of Clinical Oncology 22:6(#19)
Year
2003
Research Committee(s)
Breast
Study Number(s)
SWOG-9061 (EST-2190) (INT-0121)

LVEF assessment of adjuvant doxorubicin/cyclophosphamide (AC) vs doxorubicin/docetaxel (AT) in early stage breast cancer: cardiac safety results of ECOG 2197.

Authors
LJ Goldstein;A O'Neill;JA Sparano;EA Perez;LN Shulman;S Martino;AC Wolff;NE Davidson
Journal / Conference
Proc of the American Society of Clinical Oncology 22:19(#73)
Year
2003
Research Committee(s)
Breast
Study Number(s)
E2197